Sven Guenther's most recent trade in Zevra Therapeutics Inc was a trade of 79,000 Restricted Stock Unit done . Disclosure was reported to the exchange on Jan. 31, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | Sven Guenther | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 79,000 | 79,000 | - | - | Restricted Stock Unit | |
| Zevra Therapeutics Inc | Sven Guenther | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 306,000 | 306,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Sven Guenther | EVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 83,486 | 83,486 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Sven Guenther | EVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 81,716 | 81,716 | - | - | Stock Option (right to buy) |